Clinical Trials Logo
  1. Home
  2. Sickle Cell Crisis
  3. NCT03477552

Transillumination Device for Peripheral Intravenous Placement in Patients With Sickle Cell Disease (PERFID) — PERFID  

Sickle Cell Crisis Clinical Trial

Official title:
Efficacy of AccuVein V400 to Facilitate Peripheral Intravenous Placement in Sickle Cell Disease Adults With Vaso-occlusive Crisis : a Randomized Clinical Trial

Clinical Trial Summary

The primary goal of this randomized, controlled, open-label study is to determine the efficacy of AccuveinV400 (a transillumination veins device) to facilitate peripheral intravenous (IVP) catheter placement during a vaso-oclusive crisis. The investigators hypothesized that the number of attempts to a successful placement of a peripheral IV, our primary outcome, would be shorter with the assistance of the Accuvein V400. It is also expected that AccuveinV400 will reduce the time of the procedure, the rate of failure, the technique-related pain.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03477552
Study type Interventional
Source Assistance Publique - Hôpitaux de Paris
Contact
Status Completed
Phase N/A
Start date March 30, 2018
Completion date May 30, 2022
View Details
See also
  Status Clinical Trial Phase
Completed NCT01319448 - Intermittent Preventive Treatment for Malaria in Patient With Sickle Cell Disease Phase 1/Phase 2
Recruiting NCT05373771 - Sickle Cell Improvement: Enhancing Care in the Emergency Department N/A
Completed NCT02316366 - The Use of Warmed Saline in Vaso-occlusive Episodes N/A
Completed NCT05572294 - Mindfulness and Yoga Therapy for Acute Pain in Sickle Cell Disease N/A
Not yet recruiting NCT05864092 - Virtual Reality as an Adjuvant Therapy for Sickle Cell Vaso-Occlusive Crisis in the Pediatric Emergency Department N/A
Completed NCT03901560 - Music Therapy: Sickle Cell and Pain Crisis
Completed NCT02434939 - Low-dose Ketamine vs Morphine for Vaso-occlusive Crisis in Sicklers Phase 4
Recruiting NCT04076748 - Evaluation of the Efficacy of Intra-nasal Sufentanil for Analgesia of Vaso-occlusive Crisis in Sickle-cell Adults. Phase 3
Completed NCT04330183 - Low Dose Ketamine and Acute Pain Crisis Phase 4
Not yet recruiting NCT04614610 - Lidocaine Intravenous in the Emergency Department For Sickle Cell Crisis Phase 2
Recruiting NCT03431285 - Ketamine for Acute Painful Crisis in Sickle Cell Disease Patients N/A
Terminated NCT02698761 - A Comprehensive Care Plan for Pediatric Patients With Vaso-Occlusive Crises N/A